2025 Preview
Biotech will remain in recovery mode next year, after hitting rock bottom in 2023 amid a post-pandemic rout. The sector has taken its time recuperating from those lows, and there are few reasons to expect a rapid rally in 2025.
Foreword
Innovation and Regulation
Analysis
Money, Markets and M&A
Eyes on China
How We Help
Related Reourses
Contact us for more information